Swipe from Facebook:
View attachment 1597582
Scientists examined how certain flavoring chemicals commonly used in vaping products affect human airway cells in controlled laboratory studies. Some compounds were associated with increased inflammation, oxidative stress, impaired wound healing, and disruption of normal cellular repair processes in the lung epithelium. These effects were observed at concentrations relevant to typical vaping exposure, raising concerns that repeated use of certain flavored e-liquids could contribute to chronic airway damage or conditions resembling bronchiolitis obliterans (sometimes called “popcorn lung”) or other forms of vaping-related lung injury.
The findings come from controlled in vitro and ex vivo studies and require broader confirmation through additional preclinical models, longitudinal human cohort studies, and larger-scale clinical investigations. Not all vaping products or flavor exposures are identical—different brands, devices, power settings, puffing behaviors, and specific chemical formulations can produce widely varying levels of risk. Long-term health effects of vaping, including the role of flavors versus nicotine or base solvents, are still being mapped, with many questions remaining about dose-response relationships, susceptibility in adolescents versus adults, and interactions with other environmental exposures.
Public health agencies, including the CDC, FDA, and WHO, continue to urge caution, especially for teens and young adults, due to the developing lung and brain, higher addiction potential, and emerging evidence of respiratory harm. Quitting all nicotine and vaping products remains the lowest-risk option for current users, with behavioral support, counseling, and FDA-approved cessation aids recommended as the most effective path.
More peer-reviewed data from independent replication, real-world epidemiology, and mechanistic studies will be needed to clarify the degree of harm attributable specifically to flavored e-cigarettes versus vaping in general. The study adds to growing concern about flavored vaping products, particularly their appeal to youth and potential role in chronic lung disease.
References
American Journal of Respiratory and Critical Care Medicine – Flavoring chemicals in e-cigarettes impair airway epithelial repair and induce inflammation (2026)
Environmental Health Perspectives – Toxicological assessment of common e-cigarette flavorants on lung cells (2025–2026)
CDC – Health Effects of Vaping & E-Cigarette Use (updated 2026)
FDA – Update on Vaping-Associated Lung Injury and Flavored Products (February 2026)
The New England Journal of Medicine – Long-term respiratory outcomes in youth e-cigarette users (2026 review)
World Health Organization – Electronic Nicotine Delivery Systems: Health Risks and Regulation (2026)
View attachment 1597583
